ArticleBMC medical imaging2026
An explainable multimodal 2.5D deep learning-radiomics model for predicting extranodal extension in lung adenocarcinoma using preoperative CT: a multicenter retrospective cohort study.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectiveThis study aimed to develop the Radiomics-Assembled ENE system (RAIEm), a multimodal preoperative computed tomography (CT) radiomics model, for identifying extranodal extension (ENE) in lung adenocarcinoma (LUAD) and to examine its utility in risk stratification and individualized treatment planning.
methodsWe retrospectively assembled preoperative thin-slice chest CT scans and postoperative hematoxylin-eosin-stained histology from patients with LUAD. Tumors were segmented automatically using a 3D U-Net with virtual adversarial training. Radiomic features were derived from the intratumoral region and from concentric peritumoral rings expanded by 2, 4, 6, and 8 mm, and 2.5D deep-learning features were extracted from five axial CT slices centered on the largest tumor section using a convolutional neural network. Subsequently, we constructed an integrated Radiomics-ENE model (RAIEm), whose performance was assessed in separate training and validation cohorts.
resultsRAIEm outperformed conventional unimodal models, yielding higher area under the receiver operating characteristic curve (AUC), sensitivity, and specificity in both the training and external validation cohorts. In the validation cohort, AUC was 0.78 (95% CI, 0.66-0.89), and decision-curve analysis indicated greater net benefit across most threshold probabilities. RAIEm demonstrated significant discriminative power for recurrence-free survival risk stratification in both the training and external validation cohorts (both p < 0.01). ENE-positive patients showed significantly shorter recurrence-free survival than ENE-negative patients in both cohorts. Shapley Additive Explanations (SHAP) analysis highlighted key radiomic drivers, with deep-learning features (one 2D and two 2.5D) ranking among the top three contributors.
conclusionRAIEm - a multimodal, preoperative CT radiomics-based model - showed encouraging performance for identifying ENE in LUAD and may support preoperative risk assessment; however, prospective multicenter validation is required before routine clinical implementation.
Indexed as
Identifiers
42458284What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.